Cancer Immunotherapy: Bridging Basic Research and Clinical Translation (A1)
January 24-27, 2027
| Beaver Run Conference Center, Breckenridge, CO, United States
Ana Carrizosa Anderson, Drew M. Pardoll, Neta Erez and Ivan Diaz-Padilla
Scholarship Deadline: Sep. 30, 2026 | Abstract Deadline: Jan. 5, 2027 | Early Registration Deadline: Nov. 24, 2026
| 4:00–8:00 PM |
Registration |
Colorado Ballroom Foyer |
| 6:00–8:00 PM |
Welcome Mixer |
Colorado Ballroom Foyer |
| 7:00–8:00 AM |
Breakfast |
Summit Gallery |
| 8:00–8:10 AM |
Welcome Remarks |
Colorado Ballroom Peak 4-5 |
| 8:10–9:00 AM |
Keynote Address |
Colorado Ballroom Peak 4-5 |
| |
Antoni Ribas, University of California, Los Angeles
How Tumors Enable Immunotherapy |
|
| 9:00–11:15 AM |
Reimagining Checkpoint Targeted Therapies |
Colorado Ballroom Peak 4-5 |
| |
Ivan Diaz-Padilla, Ipsen, Oncology Global Research & Development
Lessons from Checkpoint Blockade Trials |
|
| |
Andrea Cercek, Memorial Sloan Kettering Cancer Center
Neoadjuvant Checkpoint Blockade in MMRd Cancer |
|
| |
Drew M. Pardoll, Johns Hopkins University School of Medicine
Understanding Resistance to Checkpoint Inhibition based on Neoadjuvant Clinical Trials |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 9:30–9:50 AM |
Coffee Break |
Colorado Ballroom Foyer |
| 11:25–12:25 PM |
Panel Discussion: Circadian Control of Immunotherapy |
Colorado Ballroom Peak 4-5 |
| 12:25–1:00 PM |
Poster Setup |
Colorado Ballroom Peak 1-3 |
| 12:25–2:30 PM |
On Own for Lunch |
|
| 1:00–10:00 PM |
Poster Viewing |
Colorado Ballroom Peak 1-3 |
| 2:30–4:30 PM |
Symposia Spotlight 1: Cancer-Neuroimmunology |
Colorado Ballroom Peak 4-5 |
| |
Short Talks Chosen from Abstracts
|
|
| 4:30–5:00 PM |
Coffee Available |
Colorado Ballroom Foyer |
| 5:00–7:00 PM |
Biological Insights from Systems that Model Human Cancer |
Colorado Ballroom Peak 4-5 |
| |
Daniela Thommen, Netherlands Cancer Institute
Rewiring T Cells in PD1 Resistant Tumors |
|
| |
Neta Erez, Weizmann Institute of Science
Stromal and Immune Plasticity Shape the Metastatic Niche |
|
| |
Raza Ali, University of Cambridge
Systems Cancer Pathology |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 7:00–8:00 PM |
Social Hour with Dinner |
Summit Gallery |
| 7:30–10:00 PM |
Poster Session 1 |
Colorado Ballroom Peak 1-3 |
Tuesday, January 26, 2027
| 7:00–8:00 AM |
Breakfast |
Summit Gallery |
| 8:00–11:00 AM |
Harnessing Innate Cells for Cancer Therapy |
Colorado Ballroom Peak 4-5 |
| |
Adelheid Cerwenka †, University of Heidelberg
Talk Title to be Announced |
|
| |
Seth B Coffelt, University of Glasgow
gamma delta T Cells as Architects of the Tumor Microenvironment |
|
| |
Judith A. Varner, University of California, San Diego
Macrophage Directed Immunotherapies |
|
| |
Marco Colonna, Washington University School of Medicine
Trem2 based Therapies in Cancer |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 9:00–9:20 AM |
Coffee Break |
Colorado Ballroom Foyer |
| 11:00–1:00 PM |
Poster Setup |
Colorado Ballroom Peak 1-3 |
| 11:00–3:00 PM |
On Own for Lunch |
|
| 1:00–10:00 PM |
Poster Viewing |
Colorado Ballroom Peak 1-3 |
| 3:00–4:30 PM |
Career Roundtable |
Colorado Ballroom Peak 4-5 |
| 4:30–5:00 PM |
Coffee Available |
Colorado Ballroom Foyer |
| 5:00–7:00 PM |
Mechanisms Shaping T Cell Differentiation in Cancer |
Colorado Ballroom Peak 4-5 |
| |
Mary Philip, Vanderbilt University Medical Center
Early CD8+ T Cell Fate Commitment in Cancer |
|
| |
Ana Carrizosa Anderson, Harvard Medical School
Transcriptional Control of CD8+ T Cell State Transitions |
|
| |
Jean-Christophe Beltra, University of Basel
Cytokine-Directed Gene Programs Shaping CD8+ T Cell Differentiation in Cancer |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 7:00–8:00 PM |
Social Hour with Dinner |
Summit Gallery |
| 7:30–10:00 PM |
Poster Session 2 |
Colorado Ballroom Peak 1-3 |
Wednesday, January 27, 2027
| 7:00–8:00 AM |
Breakfast |
Summit Gallery |
| 8:00–11:00 AM |
Applying Engineering and Materials Science to Cancer Immunotherapy |
Colorado Ballroom Peak 4-5 |
| |
David J. Mooney, Harvard University
Engineering T Cell Cancer Therapies |
|
| |
Jason Luke, Strand Therapeutics
Cell-Type Specific Delivery and Regulation of mRNA Therapeutics and in vivo Cell Therapy |
|
| |
Peter Benedict Kirk, Immunocore
T Cell Engagers for Solid Tumor Indications |
|
| |
Jamie Spangler, Johns Hopkins University
Engineering Proteins for Immunotherapy |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 9:00–9:20 AM |
Coffee Break |
Colorado Ballroom Foyer |
| 11:00–2:30 PM |
On Own for Lunch |
|
| 2:30–4:30 PM |
Symposia Spotlight 2 |
Colorado Ballroom Peak 4-5 |
| |
Short Talks Chosen from Abstracts
|
|
| 4:30–5:00 PM |
Coffee Available |
Colorado Ballroom Foyer |
| 5:00–6:15 PM |
Pushing the Envelope in Cancer Vaccines: Generation and Application |
Colorado Ballroom Peak 4-5 |
| |
Anna Morena D'Alise, Nouscom Srl
Talk Title to be Announced |
|
| |
Lélia Delamarre, Genentech, Inc.
Individualized Neoantigen RNA Vaccines |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 6:15–7:05 PM |
Closing Keynote Address |
Colorado Ballroom Peak 4-5 |
| |
Yardena Samuels, Weizmann Institute of Science
Novel Mechanisms Producing Targetable Tumor Antigens |
|
| 7:05–7:15 PM |
Meeting Wrap-Up: Outcomes and Future Directions (Organizers) |
Colorado Ballroom Peak 4-5 |
| 7:15–8:15 PM |
Social Hour with Dinner |
Summit Gallery |
| 8:00–9:00 PM |
Entertainment |
|
Thursday, January 28, 2027
